Methodological Limitations

• The paper is a commentary/opinion piece rather than original empirical research, yet it makes strong causal claims about iatrogenic harm without presenting original data or systematic evidence.
• The author relies heavily on a limited and potentially biased set of sources, particularly the work of Lisa Littman, whose research on 'rapid-onset gender dysphoria' has been widely criticized for methodological flaws including non-representative sampling from parent-report surveys on detransitioner websites.
• The claim that 10-30% discontinue medical transition within 16 months to four years conflates treatment discontinuation with detransition and regret—Hall et al. (2021) and Roberts et al. (2022) studies cited do not establish that all discontinuation represents regret or iatrogenic harm, as discontinuation may occur for financial, access, or other reasons.
• The author interprets high loss-to-follow-up in historical studies as evidence of hidden regret, but this is speculative—loss to follow-up is a common methodological challenge that does not necessarily indicate negative outcomes.
• The paper presents a false equivalence between historical iatrogenic harms (fenfluramine, Vioxx, opioids) with established causal pathways and gender-affirming care, where the evidence base is still developing but the comparison prejudges the conclusion.
• The author dismisses minority stress theory and attributes co-occurring mental health conditions to pre-existing factors without acknowledging the extensive body of research supporting minority stress mechanisms in LGBTQ+ populations.
• The claim that 'every major medical association' supports is 'not based on compelling evidence' contradicts the systematic reviews and clinical guidelines those same organizations have developed, yet the author provides no systematic rebuttal of their evidence base.
• The paper selectively cites international reviews (Cass, NICE, COHERE) without noting that these reviews generally supported continued access to care with improved assessment protocols rather than wholesale rejection of gender-affirming medicine.
• The author characterizes detransitioners as 'survivors of iatrogenic harm' throughout, framing the conclusion before establishing the evidentiary basis, which constitutes circular reasoning.
• No data is presented on the denominator of total patients treated versus those who detransition, making it impossible to assess actual rates of harm from the claims made.
• The paper acknowledges 'no single narrative' captures detransitioner experiences but then presents primarily one narrative (internal factors, trauma, social media) while minimizing structural factors that research has identified.
• The author claims WPATH SOC-8 'chose not to include a chapter on detransition' without acknowledging that the document does address discontinuation of treatment and that WPATH has stated detransition care is integrated throughout rather than siloed in a separate chapter.
• The suicide prevention claims attributed to clinicians are presented without representative evidence of how frequently such claims are made or by whom, relying instead on media investigations and individual critical accounts.